SEC-sourced researchBeta
OPRX
OptimizeRx Corp
Company comparison ↗
Data passport
- CIK
- 0001448431
- Exchange
- Nasdaq
- Business activity
- — · SIC 7389
- Financial inputs
- 6/6
- Filing date
- Oct 2, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 92,127,000.0000 | Mar 12, 2026 |
| December 2025 | 109,429,000.0000 | Mar 12, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 109,429,000.0000 | 5,132,000.0000 | 18,715,000.0000 | 176,918,000.0000 | 48,624,000.0000 | Mar 12, 2026 |
| December 2024 | 92,127,000.0000 | -20,110,000.0000 | 4,889,000.0000 | 171,168,000.0000 | 54,170,000.0000 | Mar 12, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $109.43M | December 2025 | Mar 12, 2026 | 10-K |
| Previous period revenueRevenues | $92.13M | December 2024 | Mar 12, 2026 | 10-K |
| Net incomeNetIncomeLoss | $5.13M | December 2025 | Mar 12, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $18.72M | December 2025 | Mar 12, 2026 | 10-K |
| Total assetsAssets | $176.92M | December 2025 | Mar 12, 2026 | 10-K |
| Total liabilitiesLiabilities | $48.62M | December 2025 | Mar 12, 2026 | 10-K |